The Clinical Trials Software Market Size is valued at USD 0.79 billion in 2023 and is predicted to reach USD 2.28 billion by the year 2031 at a 14.20 % CAGR during the forecast period for 2024-2031.
Recently pharmaceutical companies started using clinical trial management services to improve the accuracy and efficiency of clinical trials. A clinical trial is a procedure that studies new treatments and drugs to check their effects on human health.
The rising use of clinical trial management services, fast adoption of cloud-based solutions, increased healthcare expenditure, high prevalence of chronic & infectious diseases, growing government investments for clinical trial services and research are projected to augument the market growth over the forecast period. Furthermore, rising innovations of clinical trials software drive the market growth. For instance, in April 2021, Bioclinica (US) introduced the new source document management solution that combines advanced software with redaction and translation services to offer support to global research sites and trial management teams.
However, the expensive clinical trials software and limited knowledge on advanced technologies among healthcare professionals may restrict the market growth during the estimated timeframe.
Competitive Landscape
Some of the Major Key Players in the Clinical Trials Software Market are:
- Advarra,
- Antidote Technologies, Inc.,
- ArisGlobal,
- AssistRx,
- athenahealth, Inc.,
- Axiom Real-Time Metrics,
- BioClinica Inc.,
- BSI Business Systems Integration AG
- Calyx,
- Castor EDC,
- Chronicles,
- Clario,
- Clarivate,
- ClinCapture,
- Clincase,
- Clinical Research,
- CLIRINX,
- Cloudbyz,
- Dacima Software Inc.,
- Datatrak Int.,
- Florence HC,
- IBM,
- Instem,
- IQVIA,
- MasterControl Inc.,
- Medidata Solutions Inc,
- MedNet Solutions Inc.,
- Novatek International,
- Octalsoft,
- Openclinica,
- Oracle Corporation,
- Parexel International Corp.,
- RealTime Software Solutions LLC,
- Reify Health, Inc.,
- Signant Health,
- Statsols,
- TrialKit,
- Veeva Systems Inc.,
- WIRB-Copernicus Group,
- Other prominent players.
Market Segmentation
The clinical trials software market is segmented into the type of deployment, type of delivery, type of end-user, features of software, trial design, type of technology and region. The type of deployment segment comprises on-cloud and on-premises. The on-cloud segment is projected to dominate the market during the forecast period due to the surging use of cloud-based software for clinical trials. The market is classified into web-based and remote monitoring based on the type of delivery. The web-based delivery type is expected to be the fastest-growing segment of this market. It reduces R&D costs and offers cost-effective, easy accessibility to web-based clinical trial solutions.
Type of End-User, the market segmented into pharmaceuticals, biotechnology, CROs. features of software, the market segmented into EDC, eCOA/ePRO, eConsent, Trial Design the market segmented into decentralized, site-based, hybrid, randomized, case control, cohort, Type of Technology the market segmented into IVRS, and IWRS.
The pharmaceutical category will lead this market in the coming years due to the high demand for automated clinical trial management services. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
North America dominated the clinical trials software market in 2020 and will continue its trend over the forecast period. Additionally, the Asia-Pacific market is likely to witness rapid growth in the next few years due to the growing pharmaceutical companies, increasing clinical trial studies, and high demand for web-based and cloud-based solutions for clinical trial processes.
The Clinical Trials Software Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 0.79 billion |
|
Revenue Forecast In 2031 |
USD 2.28 billion |
|
Growth Rate CAGR |
CAGR of 14.20 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Type of Deployment, Type of Delivery, Type of End-User, Features of Software, Trial Design, Type of Technology |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Advarra, Antidote Technologies, Inc., ArisGlobal , AssistRx, athenahealth, Inc., Axiom Real-Time Metrics, BioClinica Inc. , BSI Business Systems Integration AG, Calyx , Castor EDC, Chronicles, Clario, Clarivate, ClinCapture, Clincase, Clinical Research, CLIRINX, Cloudbyz, Dacima Software Inc., Datatrak Int. , Florence HC , IBM , Instem , IQVIA , MasterControl Inc., Medidata Solutions Inc, MedNet Solutions Inc., Novatek International, Octalsoft , Openclinica, Oracle Corporation, Parexel International Corp., RealTime Software Solutions LLC, Reify Health, Inc., Signant Health, Statsols, TrialKit , Veeva Systems Inc., WIRB-Copernicus Group, and Other prominent players. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
